156 related articles for article (PubMed ID: 3814920)
1. Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve.
Ireland SJ; Tyers MB
Br J Pharmacol; 1987 Jan; 90(1):229-38. PubMed ID: 3814920
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
[TBL] [Abstract][Full Text] [Related]
3. Origin of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion and vagus nerve.
Ireland SJ
Br J Pharmacol; 1987 Oct; 92(2):407-16. PubMed ID: 3676601
[TBL] [Abstract][Full Text] [Related]
4. Influence of 5-hydroxytryptamine uptake on the apparent 5-hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglion.
Ireland SJ; Straughan DW; Tyers MB
Br J Pharmacol; 1987 Jan; 90(1):151-60. PubMed ID: 3814917
[TBL] [Abstract][Full Text] [Related]
5. The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.
Butler A; Elswood CJ; Burridge J; Ireland SJ; Bunce KT; Kilpatrick GJ; Tyers MB
Br J Pharmacol; 1990 Nov; 101(3):591-8. PubMed ID: 2076479
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxytryptamine (5-HT)-induced depolarization in isolated abdominal vagus nerves in the rat: involvement of 5-HT3 and 5-HT4 receptors.
Nemoto M; Endo T; Minami M; Yoshioka M; Ito H; Saito H
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):217-30. PubMed ID: 11758651
[TBL] [Abstract][Full Text] [Related]
7. Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists.
Round A; Wallis DI
Neuropharmacology; 1987 Jan; 26(1):39-48. PubMed ID: 3561718
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion.
Ireland SJ; Jordan CC
Br J Pharmacol; 1987 Oct; 92(2):417-27. PubMed ID: 3676602
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of the 5-hydroxytryptamine-induced depolarization of the ferret vagus nerve in vitro.
Newberry NR; Watkins CJ; Reynolds DJ; Leslie RA; Grahame-Smith DG
Eur J Pharmacol; 1992 Oct; 221(1):157-60. PubMed ID: 1459188
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of the effects of 5-hydroxytryptamine on the rabbit isolated vagus nerve by BRL 43694 and metoclopramide.
Elliott P; Seemungal BM; Wallis DI
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):503-9. PubMed ID: 2168021
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats.
Yoshioka M; Ikeda T; Abe M; Togashi H; Minami M; Saito H
Br J Pharmacol; 1992 Jul; 106(3):544-9. PubMed ID: 1387026
[TBL] [Abstract][Full Text] [Related]
12. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
[TBL] [Abstract][Full Text] [Related]
13. 5-hydroxytryptamine3 (5-HT3) receptor-mediated depolarisation of the rat isolated vagus nerve: modulation by trichloroethanol and related alcohols.
Bentley KR; Barnes NM
Eur J Pharmacol; 1998 Jul; 354(1):25-31. PubMed ID: 9726627
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.
Eglen RM; Swank SR; Walsh LK; Whiting RL
Br J Pharmacol; 1990 Nov; 101(3):513-20. PubMed ID: 2076474
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxytryptamine depresses depolarizing responses to GABA in the rat isolated vagus nerve.
Pike GK; Kerr DI
Eur J Pharmacol; 1986 Nov; 131(2-3):297-300. PubMed ID: 3816958
[TBL] [Abstract][Full Text] [Related]
16. [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.
Hoyer D; Waeber C; Karpf A; Neijt H; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):396-402. PubMed ID: 2586633
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the in vitro effects of 5-hydroxytryptamine (5-HT) on identified neurones of the rat dorsal motor nucleus of the vagus (DMV).
Browning KN; Travagli RA
Br J Pharmacol; 1999 Nov; 128(6):1307-15. PubMed ID: 10578146
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.
Ito H; Akuzawa S; Tsutsumi R; Kiso T; Kamato T; Nishida A; Yamano M; Miyata K
Neuropharmacology; 1995 Jun; 34(6):631-7. PubMed ID: 7566499
[TBL] [Abstract][Full Text] [Related]
20. AS-5370 potently antagonizes 5-HT3 receptor-mediated responses on NG108-15 cells and on the rat vagus.
Newberry NR; Sprosen TS; Watkins CJ; Leslie RA; Grahame-Smith DG
Eur J Pharmacol; 1992 Aug; 219(1):135-40. PubMed ID: 1397040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
